Jacobs & Co Buys Amazon.com Inc, Union Pacific Corp, Regeneron Pharmaceuticals Inc, Sells Biogen Inc, NXP Semiconductors NV, Pro Medicus

• New Purchases: AMZN, UNP, REGN, ZEN, CMCSA,
• Added Positions: DTEGY, ABBV, YUM, CMI, ADP, UPS, SYY, MDLZ, GLW, BDX, AMGN, GE, MKC, MRK, EMR, JPM, VOD,
• Reduced Positions: AAPL, NXPI, CVX, SLB, MSFT, ADBE, GOOGL, EA, FB, INTC, COST, PYPL, V, ZTS, EW, NKE, ENB, BMY, GOOG, TSLA, MCD, AMAT, DE, LH, INTU, MDT, NVDA, HD, FDX, YUMC, MMM, PFE, RDS.A, XOM, GSK, STZ, CAT, CSX, ABT, T, ZBH, RTN, PEP, HON, WTS, MAS, PNR, LLY, BAX, AXP, BP, NVT, ELAN, SCHB,
• Sold Out: BIIB, PMCUF, TELL, PSX, RHHBY, CVGW, MPC, DD, EIX, SRE, DOW, MSI, IOSP, HPE,

For the details of JACOBS & CO's stock buys and sells, go to https://www.gurufocus.com/guru/jacobs+%26+co/current-portfolio/portfolio

1. Apple Inc (AAPL) - 91,056 shares, 4.52% of the total portfolio. Shares reduced by 11.75%
2. Microsoft Corp (MSFT) - 121,704 shares, 3.75% of the total portfolio. Shares reduced by 4.87%
3. Amazon.com Inc (AMZN) - 9,046 shares, 3.44% of the total portfolio. New Position
4. Intel Corp (INTC) - 302,411 shares, 3.19% of the total portfolio. Shares reduced by 3.64%
5. Visa Inc (V) - 100,605 shares, 3.16% of the total portfolio. Shares reduced by 2.89%

Jacobs & Co initiated holding in Amazon.com Inc. The purchase prices were between $1676.61 and $2170.22, with an estimated average price of $1936.38. The stock is now traded at around $2162.83. The impact to a portfolio due to this purchase was 3.44%. The holding were 9,046 shares as of .

Jacobs & Co initiated holding in Union Pacific Corp. The purchase prices were between $114.04 and $187.19, with an estimated average price of $166.14. The stock is now traded at around $146.63. The impact to a portfolio due to this purchase was 1.56%. The holding were 56,759 shares as of .

Jacobs & Co initiated holding in Regeneron Pharmaceuticals Inc. The purchase prices were between $336.18 and $494.43, with an estimated average price of $411.31. The stock is now traded at around $510.04. The impact to a portfolio due to this purchase was 0.57%. The holding were 5,964 shares as of .

Jacobs & Co initiated holding in Zendesk Inc. The purchase prices were between $54.74 and $90.48, with an estimated average price of $78.3. The stock is now traded at around $67.97. The impact to a portfolio due to this purchase was 0.09%. The holding were 7,409 shares as of .

Jacobs & Co initiated holding in Comcast Corp. The purchase prices were between $33.37 and $47.5, with an estimated average price of $42.37. The stock is now traded at around $37.24. The impact to a portfolio due to this purchase was 0.05%. The holding were 6,929 shares as of .

Jacobs & Co added to a holding in Deutsche Telekom AG by 29.28%. The purchase prices were between $11.82 and $17.93, with an estimated average price of $15.65. The stock is now traded at around $13.39. The impact to a portfolio due to this purchase was 0.12%. The holding were 201,277 shares as of .

Jacobs & Co sold out a holding in Biogen Inc. The sale prices were between $268.85 and $341.04, with an estimated average price of $303.55.

Jacobs & Co sold out a holding in Pro Medicus Ltd. The sale prices were between $8.55 and $18.35, with an estimated average price of $14.55.

Jacobs & Co sold out a holding in Tellurian Inc. The sale prices were between $0.69 and $8.69, with an estimated average price of $4.89.

Jacobs & Co sold out a holding in Phillips 66. The sale prices were between $42.09 and $112.2, with an estimated average price of $82.3.

Jacobs & Co sold out a holding in Roche Holding AG. The sale prices were between $35.26 and $44.73, with an estimated average price of $41.2.

Jacobs & Co sold out a holding in Calavo Growers Inc. The sale prices were between $51.07 and $90.59, with an estimated average price of $71.15.